AltraVax

About:

Altravax was incorporated in 2009 and is a privately held biopharmaceutical company based in North Dakota with research facilities in

Website: http://altravax.com

Twitter/X: altravax

Description:

Altravax was incorporated in 2009 and is a privately held biopharmaceutical company based in North Dakota with research facilities in Sunnyvale, California. The Company is focused on the discovery and development of novel products to fight infectious diseases and other conditions. Our proprietary Immunogen Optimization Systemâ„¢ (IOS) offers unique opportunities to create novel vaccines or improve currently available alternatives to fill unmet medical needs. The Company has a robust pipeline of candidates at various stages of development, including a therapeutic vaccine against chronic hepatitis B infection and a preventive vaccine against all four dengue virus. Altravax seeks strategic alliances to develop these lead candidates for clinical testing.

Total Funding Amount:

$2.01M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Sunnyvale, California, United States

Founded Date:

2009-01-01

Contact Email:

service(AT)altravax.com

Founders:

Michael Chambers, Robert Whalen, Sean Du

Number of Employees:

11-50

Last Funding Date:

2009-11-30

IPO Status:

Private

Industries:

© 2025 bioDAO.ai